Last reviewed · How we verify
H. pylori eradication scheme D
At a glance
| Generic name | H. pylori eradication scheme D |
|---|---|
| Also known as | Sequential |
| Sponsor | Unidade Local de Saúde de Coimbra, EPE |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- A Real World Study of Bismuth Colloidal Pectin Granules Quadruple Therapy for H. Pylori Eradication (PHASE4)
- Helicobacter Pylori Eradication Therapy in Portugal (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- H. pylori eradication scheme D CI brief — competitive landscape report
- H. pylori eradication scheme D updates RSS · CI watch RSS
- Unidade Local de Saúde de Coimbra, EPE portfolio CI